Pemigatinib for Myeloid/Lymphoid Neoplasms with <i>FGFR1</i> RearrangementSrđan Verstovšek, Jason Gotlib, Jean‐Jacques Kiladjian et al.|NEJM Evidence|2025Cited by 7